We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Robotic-Assisted Surgery for Gallbladder Cancer Found To Be As Effective As Traditional Surgery

By HospiMedica International staff writers
Posted on 06 Mar 2024

Gallbladder cancer (GBC), ranking as the leading biliary tract cancer and the 17th deadliest cancer globally, demands urgent improvement in disease management. More...

Surgery remains the most effective curative approach for those diagnosed with GBC. Despite the growing preference for minimally invasive surgical methods in gastrointestinal cancers, including laparoscopic and robotic surgeries, there is still hesitancy in employing these techniques for GBC. This caution mainly stems from concerns about tumor dissemination, bile spillage, and specific technical challenges like liver resection and thorough lymph node removal. Now, a new study has found that robotic-assisted surgery for GBC matches the efficacy of conventional open and laparoscopic procedures while offering the additional advantages of high precision and faster recovery post-surgery.

Conducted by researchers at Boston University (Boston, MA, USA), this study involved a systematic review of existing literature to compare patient outcomes from robotic, open, and laparoscopic surgeries. This comprehensive analysis included studies that documented oncological outcomes and perioperative benefits, such as the duration of the operation, blood loss, and recovery time. The results indicate that robotic surgery not only stands as a safer and potentially less painful option for treating GBC but also allows for quicker recovery. This finding has clinical implications, suggesting that robotic surgery might become a standard care option for GBC. Such a shift could enhance patient care and possibly lower healthcare expenses, owing to reduced lengths of hospital stays.

“Our study demonstrates the viability of robotic surgery for gallbladder cancer treatment, a field where minimally invasive approaches have been cautiously adopted due to concerns over oncologic efficacy and technical challenges,” said Eduardo Vega, MD, assistant professor of surgery at Boston University Chobanian & Avedisian School of Medicine.

Related Links:
Boston University


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Pocket Fetal Doppler
CONTEC10C/CL
New
Captivator EMR Device
Captivator Endoscopic Mucosal Resection Device
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: the deep tissue in vivo sound printing (DISP) platform, which combines ultrasound with low-temperature–sensitive liposomes loaded with crosslinking agents (Photo courtesy of Elham Davoodi and Wei Gao/Caltech)

New Ultrasound-Guided 3D Printing Technique to Help Fabricate Medical Implants

3D bioprinting technologies hold considerable promise for advancing modern medicine by enabling the production of customized implants, intricate medical devices, and engineered tissues designed to meet... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.